RESEARCH-USE BIOSIMILAR ANTIBODY
Ralpancizumab
Monoclonal antibody · IgG2
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
TARGETPCSK9
YMonoclonal antibody
CATALOGSC-BS-247
CATALOG NUMBERSC-BS-247
MOLECULAR WEIGHTApprox. 145.28 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
Ralpancizumab is a recombinant research-use antibody directed against PCSK9.